These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9630605)
41. Comparison of the mutational spectra of the lacZ transgene in four organs of the MutaMouse treated with benzo[a]pyrene: target organ specificity. Hakura A; Tsutsui Y; Sonoda J; Tsukidate K; Mikami T; Sagami F Mutat Res; 2000 Feb; 447(2):239-47. PubMed ID: 10751607 [TBL] [Abstract][Full Text] [Related]
42. Genotoxicity of 3-nitrobenzanthrone and 3-aminobenzanthrone in MutaMouse and lung epithelial cells derived from MutaMouse. Arlt VM; Gingerich J; Schmeiser HH; Phillips DH; Douglas GR; White PA Mutagenesis; 2008 Nov; 23(6):483-90. PubMed ID: 18635558 [TBL] [Abstract][Full Text] [Related]
43. Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice. Wild D; Gocke E; Harnasch D; Kaiser G; King MT Mutat Res; 1985; 156(1-2):93-102. PubMed ID: 3923347 [TBL] [Abstract][Full Text] [Related]
44. Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse. Smith CC; Archer GE; Forster EJ; Lambert TR; Rees RW; Lynch AM Environ Mol Mutagen; 1999; 34(2-3):131-9. PubMed ID: 10529737 [TBL] [Abstract][Full Text] [Related]
45. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317 [TBL] [Abstract][Full Text] [Related]
46. Quinoline: conversion to a mutagen by human and rodent liver. Hollstein M; Talcott R; Wei E J Natl Cancer Inst; 1978 Feb; 60(2):405-10. PubMed ID: 340706 [TBL] [Abstract][Full Text] [Related]
47. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo. Shephard SE; Lutz WK; Schlatter C Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210 [TBL] [Abstract][Full Text] [Related]
48. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice. Winegar RA; Lutze LH; Hamer JD; O'Loughlin KG; Mirsalis JC Mutat Res; 1994 Jun; 307(2):479-87. PubMed ID: 7514721 [TBL] [Abstract][Full Text] [Related]
49. Is MutaMouse insensitive to clastogens? Lynch AM; Mahabir AG; Bradford A; Brockhurst K; van Benthem J; van Steeg H; Rees RW Mutat Res; 2008 Apr; 652(2):145-50. PubMed ID: 18387845 [TBL] [Abstract][Full Text] [Related]
50. Mutagenicity of ethyl carbamate to lacZ- transgenic mice. Williams CV; Fletcher K; Tinwell H; Ashby J Mutagenesis; 1998 Mar; 13(2):133-7. PubMed ID: 9568584 [TBL] [Abstract][Full Text] [Related]
51. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system. Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882 [TBL] [Abstract][Full Text] [Related]
52. Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium. Itoh S; Shimada H Mutat Res; 1998 Jan; 412(1):63-7. PubMed ID: 9508365 [TBL] [Abstract][Full Text] [Related]
53. In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo[4,5-f]quinoline, and di(2-ethylhexyl)phthalate. Kanki K; Nishikawa A; Masumura K; Umemura T; Imazawa T; Kitamura Y; Nohmi T; Hirose M Mol Carcinog; 2005 Jan; 42(1):9-17. PubMed ID: 15486947 [TBL] [Abstract][Full Text] [Related]
54. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene. Hayward JJ; Shane BS; Tindall KR; Cunningham ML Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147 [TBL] [Abstract][Full Text] [Related]
55. Integration of sperm DNA damage assessment into OECD test guidelines for genotoxicity testing using the MutaMouse model. Maurice C; O'Brien JM; Yauk CL; Marchetti F Toxicol Appl Pharmacol; 2018 Oct; 357():10-18. PubMed ID: 30165057 [TBL] [Abstract][Full Text] [Related]
56. Effect of 10-aza-substitution on benzo[a]pyrene mutagenicity in vivo and in vitro. Yamada K; Suzuki T; Kohara A; Hayashi M; Hakura A; Mizutani T; Saeki K Mutat Res; 2002 Nov; 521(1-2):187-200. PubMed ID: 12438015 [TBL] [Abstract][Full Text] [Related]
57. Carcinogenicity and mutagenicity of heterocyclic amines in transgenic mouse models. Thorgeirsson SS; Ryu DY; Weidner V; Snyderwine EG Cancer Lett; 1999 Sep; 143(2):245-7. PubMed ID: 10503912 [TBL] [Abstract][Full Text] [Related]
58. Mutagenicity of 4-nitroquinoline 1-oxide in the MutaMouse. Nakajima M; Kikuchi M; Saeki K; Miyata Y; Terada M; Kishida F; Yamamoto R; Furihata C; Dean SW Mutat Res; 1999 Aug; 444(2):321-36. PubMed ID: 10521672 [TBL] [Abstract][Full Text] [Related]
59. Mutagenicity of pyridine- and quinoline-carbohydroxamic acid derivatives. Lipczynska-Kochany E; Iwamura H; Takahashi K; Hakura A; Kawazoe Y Mutat Res; 1984 Mar; 135(3):139-48. PubMed ID: 6369125 [TBL] [Abstract][Full Text] [Related]
60. Genotoxicity of the food mutagen 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and analogs. Barnes WS; Lovelette CA; Tong C; Williams GM; Weisburger JH Carcinogenesis; 1985 Mar; 6(3):441-4. PubMed ID: 3884172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]